Detection and quantitation of soluble B7-H3 in expressed prostatic secretions: A novel marker in patients with chronic prostatitis

Journal of Urology

Volumn 185, Issue 2, 2011, Pages 532-537

  Wei, Xuedong ^a   Zhang, Guangbo ^b   Yuan, Hexing ^a   Ding, Xiang ^a   Li, Shuxiang ^d   Zhang, Xueguang ^d   Hou, Jianquan ^c  

^a Department of Urology ^*  (China)

^b Clinical Immunology Laboratory   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

biological markers; cytokines; pain; prostate; prostatitis

Indexed keywords

BIOLOGICAL MARKER; PROTEIN; SOLUBLE B7 H3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC BACTERIAL PROSTATITIS; CHRONIC PROSTATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; NATIONAL HEALTH ORGANIZATION; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSTATE; PROSTATE SECRETION; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STUDENT T TEST;

ADULT; AGE FACTORS; ANTIGENS, CD; BIOLOGICAL MARKERS; BODILY SECRETIONS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PELVIC PAIN; PROGNOSIS; PROSTATE; PROSTATITIS; RECEPTORS, IMMUNOLOGIC; REFERENCE VALUES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOLUBILITY; YOUNG ADULT;

EID: 78651317976     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.09.104     Document Type: Article

References (30)

1. J.N. Krieger, D.E. Riley, and P.Y. Cheah Epidemiology of prostatitis: new evidence for a world-wide problem World J Urol 21 2003 70
2. W.W. Hochreiter, R.B. Nadler, and A.E. Koch Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions Urology 56 2000 1025
3. A. Khadra, P. Fletcher, and G. Luzzi Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis BJU Int 97 2006 1043
4. L.J. Miller, K.A. Fischer, and S.J. Goralnick Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome J Urol 167 2002 753
5. M.A. Pontari, and M.R. Ruggieri Mechanisms in prostatitis/chronic pelvic pain syndrome J Urol 172 2004 839
6. R.B. Nadler, A.E. Koch, and E.A. Calhoun IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis J Urol 164 2000 214
7. P.W. Kohnen, and G.W. Drach Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study J Urol 121 1979 755
8. R.B. Alexander, F. Brady, and S. Ponniah Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins Urology 50 1997 893
9. A.I. Chapoval, J. Ni, and J.S. Lau B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production Nat Immunol 2 2001 269
10. V. Ling, P.W. Wu, and V. Spaulding Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss Genomics 82 2003 365
11. G. Zhang, J. Hou, and J. Shi Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum Immunology 123 2008 538
12. E.M. Meares, and T.A. Stamey Bacteriologic localization patterns in bacterial prostatitis and urethritis Invest Urol 5 1968 492
13. F.M. Wagenlehner, H. Schneider, and M. Ludwig A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study Eur Urol 56 2009 544
14. C.B. Lee, U.S. Ha, and S.J. Lee Preliminary experience with a terpene mixture versus ibuprofen for treatment of category III chronic prostatitis/chronic pelvic pain syndrome World J Urol 24 2006 55
15. D.A. Shoskes, K.D. Thomas, and E. Gomez Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience J Urol 173 2005 474
16. J.C. Nickel, M. Pontari, and T. Moon A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis J Urol 169 2003 1401
17. A.C. Donadio, H. Gagliano, and M.M. Remedi Time-course study of cellular immune response and testosterone metabolism in an autoimmune model for chronic prostatic inflammation J Urol 160 1998 1546
18. N.V. Desireddi, P.L. Campbell, and J.A. Stern Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome J Urol 179 2008 1857
19. M. Sun, S. Richards, and D.V. Prasad Characterization of mouse and human B7-H3 genes J Immunol 168 2002 6294
20. W.K. Suh, S.X. Wang, and A.H. Jheon The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization Proc Natl Acad Sci USA 101 2004 12969
21. P. Steinberger, O. Majdic, and S.V. Derdak Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains J Immunol 172 2004 2352
22. G.B. Zhang, H. Zhou, and Y.J. Chen Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells Tissue Antigens 66 2005 83
23. L. Luo, A.I. Chapoval, and D.B. Flies B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells J Immunol 173 2004 5445
24. C.M. Lupu, C. Eisenbach, and M.A. Kuefner An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo J Gastrointest Surg 10 2006 635
25. R. Castriconi, A. Dondero, and R. Augugliaro Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis Proc Natl Acad Sci USA 101 2004 12640
26. W.K. Suh, B.U. Gajewska, and H. Okada The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses Nat Immunol 4 2003 899
27. D.V. Prasad, T. Nguyen, and Z. Li Murine B7-H3 is a negative regulator of T cells J Immunol 173 2004 2500
28. A. Fukushima, T. Sumi, and K. Fukuda B7-H3 regulates the development of experimental allergic conjunctivitis in mice Immunol Lett 113 2007 52
29. X. Zang, R.H. Thompson, and H.A. Al-Ahmadie B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome Proc Natl Acad Sci USA 104 2007 19458
30. T.J. Roth, Y. Sheinin, and C.M. Lohse B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy Cancer Res 67 2007 7893